Chronic verrucous varicella zoster virus skin lesions: Clinical, histological, molecular and therapeutic aspects

Clinical and Experimental Dermatology

Volumn 24, Issue 5, 1999, Pages 346-353

  Nikkels, A F ^a,c   Snoeck, R ^b   Rentiert, B ^a   Pierard, G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

A 73209; ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; DNA BINDING PROTEIN; DNA POLYMERASE; FAMCICLOVIR; FOSCARNET; LOBUCAVIR; NETIVUDINE; PENCICLOVIR; SORIVUDINE; THYMIDINE KINASE; UNCLASSIFIED DRUG; VALACICLOVIR; VIRUS DNA; VIRUS PROTEIN;

ACANTHOSIS; CHRONIC DISEASE; CLINICAL FEATURE; CYTOLYSIS; ELECTRON MICROSCOPY; HERPES ZOSTER; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERKERATOSIS; KERATINOCYTE; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SMEAR; VARICELLA ZOSTER VIRUS; VIRAL SKIN DISEASE; VIRUS CULTURE;

ACYCLOVIR; ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; FOSCARNET; HERPESVIRUS 3, HUMAN; HIV INFECTIONS; HUMANS; SKIN DISEASES, VIRAL;

EID: 0032851121     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1999.00498.x     Document Type: Review

References (76)

1. Grose C. Varicella zoster virus infections: chickenpox, shingles and varicella vaccine. In: Herpes Virus Infections Glaser R, Jones JF. eds. New York: Marcel Dekker Inc., 1994: 1117-85.
2. Gilden DH, Mahalingham R, Dueland AM, Cohrs R. Herpes zoster: pathogenesis and latency. Prog Med Virol 1992; 39: 19-75.
3. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev 1996; 9: 361-81.
4. Perronne C, Lazanas M, Leport C et al. Varicella in patients infected with the human Immunodeficiency virus. Arch Dermatol 1990: 126: 1033-6.
5. Cohen PR, Beltrani VP, Grossman ME. Disseminated herpes zoster in patients with human immunodeficiency virus infection. Am J Med 1988; 84: 1076-80.
6. Nikkels AF, Delvenne P. Sadzot-Delvaux C et al Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections. J Clin Pathol 1996; 49: 243-8.
7. Whitley RJ. Gnann JW. Editorial response: herpes zoster in patients with human immunodeficiency virus infection - an ever-expanding spectrum of disease. Clin Inf Dis 1995; 21: 989-90.
8. Baselga E, Drolet BA, Segura AD, Leonardi CL, Esterly NB. Dermatomal lichenoid chronic graft-vs-host disease following varicella-zoster infection despite absence of viral genome. J Cutan Pathol 1996; 23: 576-811.
9. Nikkels AF, Sadzot-Delvaux C, Rentier B. Pierard-Franchimont C, Pierard GE. Low-productive alpha-herpesviridac infection in chronic lichenoid dermatoses. Dermatology 1998: 196: 442-6.
10. Nikkels AF, Debrus S, Sadzot-Delvaux C, Piette J, Rentier B, Pierard GE. Localization of varicella-zoster virus nucleic acids and proteins in human skin. Neurology 1995; 45: 47-9.
11. Muraki R, Iwasaki T, Sata T, Sato Y, Kurata T. Hair follicle involvement in herpes zoster: pathway of viral spead from ganglia to skin. Virchows Arch 1996: 428: 275-80.
12. Weinberg JM, Mysliwiec A, Turiansky GW, Redfield R. James WD. Viral folliculitis. Arch Dermatol 1997; 133: 983-6.
13. Jura E, Chadwick EG, Josephs SH et al. Varicella-zoster virus infections in children infected with human immunodeficiency virus. Pediatr Inject Dis J 1989: 8: 586-90.
14. Tsao II, Tahan SR. Johnson RA. Chronic varicella zoster infection mimicking a basal cell carcinoma in an AIDS patient. J Am Acad Dermatol 1997; 36: 831-3.
15. Jacobson MA, Berger TG, Fikrig S et al. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann Int Med 1990; 112: 187-91.
16. Janier M, Hillion B, Baccard M et al. Chronic varicella zoster infection in acquired immunodeficiency syndrome. J Am Acad Dermatol 1988; 18: 584-5.
17. Gallagher JG, Merigan TC. Prolonged herpes zoster infection associated with immunosuppressive therapy. Ann Int Med 1979; 91: 842-6.
18. Disler RS, Dover JS. Chronic localized herpes zoster in the acquired immunodeficiency syndrome. Arch Dermatol 1990;126: 1105-6.
19. Grossman MC, Grossman ME. Chronic hyperkeratotic herpes zoster and human immunodeficiency virus infection. I am Acad Dermatol 1993; 28: 306-8.
20. Gilson IH, Barnett JH, Conant MA, Laskin OL, Williams J. Jones PG. Disseminated ecthymatous herpes varicella zoster virus infection in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1989; 20: 637-42.
21. Tronnier M, Plettenberg A, Meigel WN, Wolff HH. Recurrent verrucous herpes zoster in an HIV patient. Demonstration of the virus by immunofluorescence and electron microscopy. Eur J Dermatol 1994; 4: 604-7.
22. Leboit PE, Limova M, Yen TSB, Palefsky JM, White CR, Berger TG. Chronic verrucous varicella zoster virus infection in patients with the acquired immunodeficiency syndrome. Am J Dermatopathol 1992; 14: 1-7.
23. Hoppenjans WB, Bibler MR, Orme RL, Solinger AM. Prolonged cutaneous herpes zoster in acquired immunodeficiency syndrome. Arch Dermatol 1990; 126: 1048-50.
24. Colebunders R, Van Damme L, Van den Abbeele K, Fleerackers Y, Van den Enden E, Dockx P. Atypical varicella-zoster infection in persons with HIV infection. Acta Clin Belg 1994; 49: 104-7.
25. Bernard P. Obel N. Chronic ulcerating acyclovir-resistant varicella zoster virus in an AIDS patient. Scand J Inf Dis 1995; 27: 623-5.
26. Leibowitz E, Kaul A, Rigaud M, Bebenroth D, Krasinski K, Borkowsky W. Chronic varicella zoster in a child infected with human immunodeficiency virus: case report and review of the literature. Cutis 1993: 49: 27-31.
27. Vaughan-Jones SA, McGibbon DH, Bradbeer CS. Chronic verrucous varicella-zoster infection in a patient with AIDS. Clin Exp Dermatol 1994; 19: 327-9.
28. Lokke-Jensen B, Weismann K, Mathiesen J., Thomsen HK. Atypical varicella-zoster infection in AIDS. Acta Derm Venereol 1993; 73: 123-5.
29. Smith KJ, Skelton HG, Frissman DM, Angritt P. Verrucous lesions secondary to DNA viruses in patients infected with the human immunodeficiency virus in association with increased factor XIII - a positive dermal dendritic cells. J Am Acad Dermatol 1992; 27: 943-50.
30. Aronson MD, Phillips CF, Gump DW, Albertini RJ, Phillips CA. Vidararbine therapy for severe herpesvirus infections: an unusual syndrome of chronic varicella and transient immunologic deficiency. J Am Med Assoc 1976; 255: 1339-42.
31. Dolin R. Reichman RC, Mazur MH, Whitley RJ. Herpes zoster-varicella infections in immunosuppressed patients. Ann Int Med 1978; 89: 375-88.
32. Nikkels AF, Pierard GE. Recognition and treatment of shingles. Drugs 1994; 48: 528-48.
33. Snoeck K. Andrei G, De Clercq E. Current pharmacological approaches to the therapy of varicella-zoster virus infections: a guide to treatment. Drugs, 1999; 57: 187-206.
34. Snoeck R, De Clercq E. Herpesvirus infections in immunocompromised patients. Cancer Treat Res 1995; 79: 149-71.
35. Ljungman P. Herpes virus infections in immunocompromised patients: problems and therapeutic interventions. Ann Med 1993; 25: 329-33.
36. Veraldi Gnecchi L, Zorzi F. Verrucous-crusted herpes zoster in an immunocompetent patient. Acta Derm Venereol 1998: 78: 236-7.
37. Pahwa S, Biron KK, Lim W et al. Continuous varicella zoster infection associated with acyclovir resistance in a child with AIDS. J Am Med Assoc 1988; 260: 2879-82.
38. Lim W, Sadick N, Gupta A, Kaplan M, Pahwa S, Skin diseases in children with HIV infection and their association with degree of immunosuppression. Int J Dermatol 1990: 29: 24-30.
39. Prose NS. HIV infection in children. J Am Acad Dermatol 1990; 22: 1223-31.
40. Tappero JW, Perkins BA, Wenger JD, Berger TG. Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus. Clin Microbiol Rev 1995: 8:440-50.
41. Alessi E. Cusini M. Zerboni R et al. Unusual varicella zoster virus infection in patients with the acquired immunodeficiency syndrome. Arch Dermatol 1988; 124: 1011-3.
42. Smith KJ, Skelton HG, Yeager J et al. Cutaneous findings in HIV-1 positive patients: a 42-month study. J Am Acad Dermatol 1994: 31: 746-54.
43. Manian FA, Kindred M, Fulling KH. Chronic varicella-zoster virus myelitis without cutaneous eruption in a patient with AIDS. report of a fatal case. Clin Inf Dis 1995: 21: 986-8.
44. Zaal MJW, Maudgal PC, Rietveld E, Suir EPE. Chronic ocular zoster. Curr Eye Res 1991, 10 (Suppl.): 125-30.
45. Nikkels AF, Rentier B, Pierard GE. Chronic varicella zoster virus skin lesions in patients with human immunodeficiency virus are related to decreased expression of gE and gB. J Infect Dis 1997: 176: 261-4.
46. Sadzot-Delvaux C. Debrus S. Nikkels AF, Piette J, Rentier B. Varicella-zoster virus latency in the adult rat is a useful model for human latent infection. Neurology 1995; 45: 18-20.
47. Debrus S, Sadzol-Delvaux C, Nikkels AF, Piette J, Rentier B. Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol 1995: 69: 3240-5.
48. Meier JL, Holman RP, Croen KD, Smialek JE, Straus S. Varicella-zoster virus transcription in human trigeminal ganglia. Virology 1993; 193: 193-200.
49. Vafai A, Murray RS, Wellish M, Devlin M, Gilden D. Expression of varicella-zoster virus and herpes simplex virus in normal human trigeminal ganglia. Proc Natl Acad Sci USA 1988; 85: 2362-6.
50. Mahalingham R, Wellish M. Cohrs R et al. Expression of protein encoded by varicella zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci USA 1996: 93: 2122-4.
51. Sadzot-Delvaux C, Thonard P, Schoonbroodt S, Piette J. Rentier B. Varicella-zoster virus induces apoptosis in cell culture. J Gen Virol 1995; 76: 2875-9.
52. Cohen JI. Infection of cells with varicella-zoster virus down-regulates surface expression of class 1 major histo-compatibility complex antigens. J Inf Dis 1998; 177: 1390-3.
53. Modiano P, Salloum E, Gillet-Terver MN et al. Acyclovir-resistant chronic cutaneous herpes simplex in Wiskott-Aldrich syndrome. Br J Dermatol 1995; 133: 475-8.
54. Safrin S, McKinley G, McKeough M, Robinson D, Spruance SL. Treatment of acyclovir unresponsive cutaneous herpes simplex virus infection with topically applied SP-303. Antiviral Res 1994; 25: 185-92.
55. Abeck D, Brandt O, Weichenthal M, Kowalzick L, Mensing H. Chronische mukokutane herpes simplex infektion. Auftreten im rahmen einer hepatisch bedingten immundefizienz. Hautarzt 1993; 44: 670-3.
56. Beasley KL, Cooley GE, Kao GF et al. Herpes simplex vegetans: atypical genital herpes infection in a patient with common variable immunodeficiency. J Am Acad Dermatol 1997; 37: 860-3.
57. Yeh V, Hopp ML, Goldstein NS, Meyer RD. Herpes simplex chronic laryngitis and vocal cord lesions in a patient with acquired immunodeficiency syndrome. Ann Otol Rhinol Laryngol 1994; 103: 726-31.
58. Chin RH, Ross BC, Taylor KI, Yung AP, Johnson PD. Chronic meningitis due to herpes simplex virus in an immunocompetent host. Eur J Clin Microbiol Inf Dis 1996; 15: 650-3.
59. Andrei G, Snoeck R, Reymen D et al. Comparative activity of selcted antiviral compounds against clinical isolates of varicella-zoster virus. Eur J Clin Microbiol infect Dis 1995; 14: 318-28.
60. Nikkels AF, Debrus S, Sadzot-Delvaux C, Piette J, Rentier B. Pierard GE. Immunohistochemical identification of Varicella-Zoster Virus gene 63-encoded protein (IE63) and Late (gE) protein on smears and cutaneous biopsies: Implications for diagnostic use. J Med Virol 1995; 47: 342-7.
61. Cavicchini S, Brezzi A, Alessi E. Ultrastructural findings in mucocutaneous infections of patients seropositive to HIV. Am J Dermatopathol 1993; 15: 320-5.
62. Lyall EGH. Ogilvie MM, Smith NM, Burns S. Acyclovir resistant varicella zoster and HIV infection. Arch Dis Child 1994;70: 133-5.
63. Ljungman P. Herpesvirus infections in immunocompromised patients: problems and therapeutic interventions. Ann Med 1993; 25: 329-33.
64. Gulick RM, Heath-Chiozzi M, Crumpacker CS. Varicella-zoster virus disease in patients with human immunodeficiency virus infection. Arch Dermatol 1990; 126: 1086-8.
65. Linnemann C Jr, Biron KK, Hoppenjans W et al. Emergence of acyclovir resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy. AIDS 1990; 4: 577-9.
66. Snoeck R, Gerard M, Sadzot-Delvaux C et al. Meningoradiculoneuritis due to acyclovir-resistant varicella zoster virus in an acquired immune deficiency syndrome patient. J Med Virol 1994; 42: 338-47.
67. Safrin S, Berger TG, Gilson I et al. Foscarnet therapy in live patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann Intern Med 1991; 115: 1921.
68. Boivin G, Edelman CK, Pednault L, Talarico CL, Biron KK, Balfour HH. Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS. J Infect Dis 1994; 170: 68-75.
69. Talarico CL, Phelps WC, Biron KK. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS. J Virol 1993; 67: 1024-33.
70. Sall RK, Kauffman L, Levy CS. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome. Arch Dermatol 1989; 125: 1548-50.
71. Fillet A-M, Visse B, Caumes E, Dumont B, Gentilini M, Huraux J-M. Foscarnet-resistant multidermatomal zoster in a patient with AIDS. Clin Inf Dis 1995; 21: 1348-9.
72. Reusser P. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 1996; 33: 235-48.
73. Balfour HH, Benson C, Braun J et al. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr 1994; 7: 254-60.
74. Rossi S, Whitfeld M, Berger TG. The treatment of acyclovir-resistant herpes zoster with trifluorothymidine and interferon alpha. Arch Dermatol 1995; 131: 24-6.
75. Martinez CM, Luks-Golger DB. Cidofovir use in acyclovir-resistant herpes infection. Ann Pharmacother 1997; 31: 1519-21.
76. Alder J. Mitten M. Norbeck D. Marsh K, Kern ER, Clement J. Efficacy of A-73209, a potent orally active agent against VZV and HSV infections. Antiviral Res 1994; 23: 93-105.